Minerva Neurosciences NERV
NASDAQ NERV
$2.47 -0.06 (-2.37%)
As of: Oct 21, 2026 · 12:49 PM EDT

Minerva Neurosciences (NERV) Acquisitions (2014)

Updated

Minerva Neurosciences' Acquisitions came in at $1.17 million for FY2014, up 84.9% from $631,478 in FY2013.

Analysis

Minerva Neurosciences (NERV) Acquisitions (2014) Analysis & Trends

  • Per Business Quant, earlier years put Acquisitions at $631,478 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn -17.24 Bn
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn -
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn -
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn -
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn -
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn 11.21 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn -
10 Minerva Neurosciences 112.54 Mn -135.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -1.17 Mn
API Access

Minerva Neurosciences Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=NERV&period=max&api_key=YOUR_API_KEY